Thomas A. Ban

Dale HH. Chemical transmission on the effects of nerve impulses.  Brit Med J 1934; 1 (3827): 835-41. 

Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954; 47: 419-27.

Beecher HK.The powerful placebo. JAMA 1955; 159: 1602-6,

Courvoisier S. Pharmacodynamic basis for the use of chlorpromazine in psychiatry. J Clin Exp Psychopathol 1956; 7: 25-37.

Ban TA. Methodology and pitfalls in clinical testing of psychopharmacologic drugs. Chemotherapia 1964; 9: 223-30.   

Elkes J. Behavioral pharmacology in relation to psychiatry. In Gruhle HW, Jung R, Mayer-Gross W,  Muller M, editors. Psychiatrie der Gegenwart. Berlin/Heidelberg/New York: Springer Verlag; 1967, pp. 929-1038.

Krieger DT, Krieger HP. Circadian pattern of plasma 17-hydroxycorticosteroid: Alterations by anticholinergic drugs. Science 1967; 155: 1421-2.

Coppen A. Depressed states and indolealkylamines. Adv Pharmacol 1968; 6: 283-91.

Wikler A. Dynamics of drug dependence. Implications of a conditioning theory  for research and treatment. Arch Gen Psyciatry 1973; 28: 611-6

Seeman P, Lee T. Antpsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975; 188: 1217-9.

Thomas A. Ban
August 27, 2015